Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablation

[1]  B. Song,et al.  Prognostic implications of CT/MRI LI‐RADS in hepatocellular carcinoma: State of the art and future directions , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[2]  John A. Onofrey,et al.  MRI Biomarkers for Prediction of Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessment of LI-RADS and Radiomic Features. , 2022, Journal of vascular and interventional radiology : JVIR.

[3]  J. Bruix,et al.  BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. , 2021, Journal of hepatology.

[4]  J. Ji,et al.  Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation. , 2021, European journal of radiology.

[5]  G. Cerri,et al.  Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study , 2021, Clinics.

[6]  S. Weng,et al.  A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation , 2021, Frontiers in Oncology.

[7]  M. Lee,et al.  Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation , 2021, European Radiology.

[8]  Zhichao Feng,et al.  Diagnostic performance of MRI using extracellular contrast agents versus gadoxetic acid for hepatocellular carcinoma: A systematic review and meta‐analysis , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[9]  A. Wienke,et al.  Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma , 2021, Liver Cancer.

[10]  E. Assenat,et al.  Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation , 2020, Hepatology communications.

[11]  Heping Wang,et al.  Pre-radiofrequency ablation MRI imaging features predict the local tumor progression in hepatocellular carcinoma , 2020, Medicine.

[12]  J. Han,et al.  Hepatobiliary phase of gadoxetic acid–enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE , 2020, European Radiology.

[13]  H. Alkadhi,et al.  Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence. , 2020, Investigative radiology.

[14]  D. Gu,et al.  Radiomics in liver diseases: Current progress and future opportunities , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Young Kon Kim,et al.  Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study. , 2020, Radiology.

[16]  D. Gerber,et al.  Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  S. Jaber,et al.  Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients , 2020, Cancers.

[18]  D. Lu,et al.  Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival , 2020, European Radiology.

[19]  M. Okada,et al.  Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation , 2020, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[20]  M. Bashir,et al.  The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. , 2019, Radiology.

[21]  J. Lee,et al.  Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis , 2019, European Radiology.

[22]  J. Babb,et al.  Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid , 2019, European Radiology.

[23]  Zhenguo Yuan,et al.  Comparison of diffusion kurtosis imaging versus diffusion weighted imaging in predicting the recurrence of early stage single nodules of hepatocellular carcinoma treated by radiofrequency ablation , 2019, Cancer Imaging.

[24]  Xinming Zhao,et al.  Histogram analysis of apparent diffusion coefficient predicts response to radiofrequency ablation in hepatocellular carcinoma , 2019, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[25]  Y. Paik,et al.  Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm , 2019, World journal of gastrointestinal oncology.

[26]  J. Han,et al.  Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC , 2019, European Radiology.

[27]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[28]  J. Shindoh,et al.  No‐touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  Eun Sun Lee,et al.  Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration , 2018, Korean journal of radiology.

[30]  Y. Ohgiya,et al.  Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images , 2018, Abdominal Radiology.

[31]  Kathryn J Fowler,et al.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. , 2018, Radiology.

[32]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[33]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[34]  J. Lee,et al.  Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources , 2018, Korean journal of radiology.

[35]  Zixing Huang,et al.  Gadoxetic acid disodium–enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta‐analysis , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[37]  Y. Imai,et al.  Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma , 2017, Digestive Diseases.

[38]  B. Taouli,et al.  One‐month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma , 2017, Journal of magnetic resonance imaging : JMRI.

[39]  Byung Chan Lee,et al.  Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging , 2017, Abdominal Radiology.

[40]  O. Yokosuka,et al.  Presence of non‐hypervascular hypointense nodules on Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging in patients with hepatocellular carcinoma , 2017, Journal of gastroenterology and hepatology.

[41]  Sin-Ho Jung,et al.  Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma , 2016, European Radiology.

[42]  Jun Kato,et al.  Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. , 2015, Journal of hepatology.

[43]  S. Ye,et al.  Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation. , 2015, Hepatobiliary & pancreatic diseases international : HBPD INT.

[44]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[45]  B. Choi,et al.  Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation. , 2015, Journal of hepatology.

[46]  S. Goldberg,et al.  Radiofrequency Ablation: Inflammatory Changes in the Periablative Zone Can Induce Global Organ Effects, including Liver Regeneration. , 2015, Radiology.

[47]  S. Goldberg,et al.  Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation. , 2015, Radiology.

[48]  Jun Kato,et al.  Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[49]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[50]  T. Tamada,et al.  Newly developed hypervascular hepatocellular carcinoma during follow-up periods in patients with chronic liver disease: observation in serial gadoxetic acid-enhanced MRI. , 2013, AJR. American journal of roentgenology.

[51]  S. Kumano,et al.  Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. , 2013, Radiology.

[52]  Ryosuke Tateishi,et al.  nature publishing group ORIGINAL CONTRIBUTIONS 569 CME Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors LIVER , 2022 .

[53]  T. Goto,et al.  Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[54]  Won Jae Lee,et al.  The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. , 2010, AJR. American journal of roentgenology.

[55]  P. V. van Diest,et al.  Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth , 2010, Journal of surgical oncology.

[56]  H. Rhim,et al.  Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. , 2008, AJR. American journal of roentgenology.

[57]  J. Willatt,et al.  MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. , 2008, Radiology.

[58]  O. Bathe,et al.  MR‐guided ablation of hepatocellular carcinoma aided by gadoxetic acid , 2007, Journal of surgical oncology.

[59]  Katsunori Saigenji,et al.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. , 2007, AJR. American journal of roentgenology.

[60]  J. Helpern,et al.  Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[61]  James Sayre,et al.  Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. , 2003, Journal of vascular and interventional radiology : JVIR.

[62]  J. Kettenbach,et al.  Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. , 2003, AJR. American journal of roentgenology.

[63]  N. Rofsky,et al.  Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. , 2000, Radiology.

[64]  J. Zucman‐Rossi,et al.  Hepatocellular carcinoma , 1998, Nature Reviews Disease Primers.

[65]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[66]  H. Toyoda,et al.  Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC , 2014, Hepatology International.

[67]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..